๐ฐ Chief Technology News
Page 42 - Chief Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chief Technology. Real-time updates on events, politics, business and more.
November 14, 2023
More than half (51%) of U.S. adults are hopeful Artificial Intelligence (AI) based applications will lead to major advancements and breakthroughs in healthcare in the year ahead but cant replace physicians, a survey shows.
November 14, 2023
The Dubai-based carrier, flydubai, announced today plans to open a USD 56 million Full-Flight Simulator (FFS) and Training Facility. The construction work has already commenced and the advanced facility is scheduled to be fully operational by January 2025
November 14, 2023
In partnership with GS Energy, Doosan Enerbility, and Samsung C&T, this Energy Exploration Center control room simulator will provide hands-on nuclear experience for future operators of NuScaleโs...
November 14, 2023
SANTA CLARA, Calif., โ Nov. 14, 2023 โ Today, AMD said its microprocessors now power 140 supercomputers on the latest Top500 list, representing a 39 [...]
November 13, 2023
Product and R&D will be centralised to better leverage Sinchโs global scale, gain efficiencies and accelerate innovation.
November 13, 2023
Robert M. Patterson to Remain in an Advisory Role Until His Retirement on May 31, 2024 Richard H. Fearon Appointed Non-Executive Chairman of the Board CLEVELAND, Nov. 13, 2023ย /PRNewswire/ --...
November 13, 2023
Pioneering Mental Well-being: Koa Health's Ethical Commitment Shines in 2022 - 2023 Ethics Audit Results
November 12, 2023
"PayPal mafia" members Elon Musk, Peter Thiel, and Reid Hoffman went from working at the startup in the early 2000s to running their own ventures.
November 10, 2023
Received FDA Agreement Under Special Protocol Assessment (SPA) for the CoMpass Phase 3 Clinical TrialPositive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with Suprachoroidal Administration Presented at AAO 2023Preliminary Data from Phase 1 Trial in...